Hengrui Of China Gets U.S. Approval For Generic Of Pfizer’s Camptosar
This article was originally published in PharmAsia News
Executive Summary
China’s Jiangsu Hengrui Medicine said it has received U.S. FDA approval to market China’s first injectable drug in the U.S.